Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam
Phase IV, observational, post-authorization, cross sectional, open-label, multicenter study to evaluate the acceptability of oral solution of levetiracetam in patients with partial epilepsy as assessed by a questionnaire.
|Study Design:||Time Perspective: Retrospective|
|Official Title:||Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam (Keppra®) (SOLUCION Study)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00319605
Show 54 Study Locations
|Study Director:||Helena Marin Muñoz, MD||UCB Pharma|